Clinical Study

EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a

Table 2

Mean values and paired changes from baseline in MSQOL-54 PCS and MCS and in EDSS scores.

DimensionBaseline12 months24 monthsEarly termination

MSQOL-54 PCS
313238182a68
Mean (SD)60.9 (19.7)65.0 (20.0)64.9 (20.3)60.7 (22.8)
Paired change from baseline
230174a66
 Mean (SD)2.0 (14.3)2.2 (15.3)0.3 (14.4)
valueb0.0140.027NS

MSQOL-54 MCS
331249191a73
Mean (SD)65.6 (20.5)71.4 (19.7)71.7 (20.0)67.3 (22.5)
Paired change from baseline
248190a72
 Mean (SD)3.7 (17.5)4.3 (19.1)1.3 (19.2)
valueb<0.00010.0003NS

EDSS score
33425119673
Mean (SD)2.0 (1.4)1.8 (1.3)1.9 (1.4)2.2 (1.8)
Paired change from baseline
25119673
 Mean (SD)−0.1 (0.9)0.1 (1.0)0.1 (1.0)
valueb0.047NSNS

MCS and PCS are expressed on a scale of 0 (poorest quality of life) to 100 (best possible quality of life). Paired changes from baseline to 24 months and ET in MSQOL-54 PCS and MCS and EDSS scores were also previously reported in Moore et al. [6].
numbers lower than 196 (number of patients who completed the 24-month study); data for these endpoints were not available for all patients who completed the study.
value calculated using a two-sided Wilcoxon matched pairs signed-rank test.
EDSS, Expanded Disability Status Scale; ET, early termination; MCS, mental health composite score; MSQOL-54, Multiple Sclerosis Quality of Life-54; NS, not statistically significant; PCS, physical health composite score; SD, standard deviation.